4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-18-058797
President and CEO sold 18,334 shares at an average $18.09 ($331,664)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2018-11-13 | Sale | −4,746 | $18.00 | $85,428 | 2,742,892 | I |
| Watts Ryan J. President and CEO | 2018-11-15 | Sale | −13,588 | $18.12 | $246,236 | 2,729,304 | I |
| Open-market sales · 18,334 sh · avg $18.09 · $331,664 | |||||||
Loading xslF345X03/doc4.xml…